All G Highlights Precision-Fermentation Lactoferrin at in-cosmetics Global

According to a recent LinkedIn post from All G, the company is exhibiting at the in-cosmetics Global trade show in Paris and highlighting its focus on bioactive ingredients produced via precision fermentation. The post centers on LFX™ lactoferrin, which is presented as a skincare-relevant protein with potential benefits for acne reduction, sebum control, inflammation pathways, and skin barrier and hydration.

The post suggests that current use of lactoferrin in skincare has been constrained by supply, variability, and cost, and positions LFX™ as a way to address those limitations for applications across skincare, oral care, and broader personal care. For investors, this emphasis indicates a strategic push into high-value cosmetic and personal care ingredients, which could open licensing or supply agreements with formulators if the technology scales and regulatory, safety, and performance hurdles are met.

By featuring its technology at a major industry event, All G appears to be targeting B2B visibility with global brands and ingredient buyers rather than direct-to-consumer marketing. If the company can convert trade show interest into commercial partnerships, its precision fermentation platform may support recurring revenue streams and enhance its positioning within the biotech-enabled beauty and personal care supply chain.

The post also underscores a broader industry trend toward bioengineered human-like proteins for topical and oral applications, where differentiation often depends on clinical data, cost efficiency, and secure supply. All G’s focus on overcoming historical constraints around lactoferrin availability could provide a pricing and reliability advantage versus traditional sources, but competitive dynamics, production economics, and customer adoption remain key variables for longer-term financial impact.